Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: A prospective randomised study

L. W. Chen, R. N. Chien*, J. J. Chang, K. M. Fang, L. C. Chang

*此作品的通信作者

研究成果: 期刊稿件 › 文章 › 同行評審

16 引文 斯高帕斯（Scopus）

指紋

深入研究「Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: A prospective randomised study」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science